Has Theodore Sebastien, MD received payments from drug or device companies?

Yes. Drug and device makers reported $525 in general payments to Theodore Sebastien, MD across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Theodore Sebastien, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Theodore Sebastien, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Theodore Sebastien, MD

MOHS-Micrographic Surgery · Reston, VANPI 1568433860

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Merz North America, Inc. at 37.1% of the total. Reporting peaked in 2023 at $235 and has fallen 86.5% since, to $32 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in VA, where the typical reported total is $1,276.

$525in general payments, 2019–2025

Across 16 payments — averaging $32.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$195
Galderma Laboratories, L.p.$115
Strata Skin Sciences, Inc.$43
Journey Medical Corporation$39
Ortho Dermatologics, A Division Of Bausch Health US, LLC$28
Regeneron Healthcare Solutions, Inc.$17
plus $88 from 6 others

What the payments were for

Food & beverage$525100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	2	$195
Galderma Laboratories, L.p.	2	$115
Strata Skin Sciences, Inc.	1	$43
Journey Medical Corporation	2	$39
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$28
Regeneron Healthcare Solutions, Inc.	1	$17
Johnson & Johnson	1	$17
Almirall LLC	1	$15
Sun Pharmaceutical Industries Inc.	1	$15
Lilly USA, LLC	1	$14
UCB, Inc.	1	$13
VYNE Pharmaceuticals Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$150
SOOLANTRA$101

How this compares

$525 in reported general payments places this provider in the 30th percentile of 36 mohs-micrographic surgery providers in Virginia.

See all mohs-micrographic surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$491,856

Medicare patients

828

Services billed

3,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Ir-DrDoxycycline Monohydrate	18	$11,186
Ivermectin	20	$5,354
Fluorouracil	74	$4,606
Clindamycin Phosphate	27	$3,554
Doxycycline Hyclate	124	$1,997
ValacyclovirValacyclovir Hcl	19	$1,415
Ketoconazole	94	$1,289
Desonide	17	$1,130
Triamcinolone Acetonide	93	$920
Metronidazole	19	$905
Minoxidil	43	$887
Mupirocin	111	$886
Finasteride	32	$642
Imiquimod	17	$628
Hydrocortisone	46	$561

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Reston

Brian JohnsonNorfolk$16K
Sherry MaraghAshburn$12K
Kristin BibeeCharlottesville$11K
Kenneth NealArlington$9K
James BotaNorfolk$9K
Brian JohnsonNorfolk$5K
Matthew WallaceRichmond$4K
Soonyou KwonVienna$4K
Amir BajoghliMc Lean$4K
Jeffrey ScottFairfax$3K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →